Litcius/Paper detail

Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

Samer Gawrieh, Srinivasan Dasarathy, Wanzhu Tu, Patrick S. Kamath, Naga Chalasani, Craig J. McClain, Ramón Bataller, Gyöngyi Szabó, Qing Tang, Svetlana Radaeva, Bruce Barton, Laura E. Nagy, Vijay H. Shah, Arun J. Sanyal, Mack C. Mitchell, Naga Chalasani, Kavish R. Patidar, Raj Vuppalanchi, Niha Samala, L Yoder, Lauren Nephew, Vijay H. Shah, Douglas A. Simonetto, Patrick S. Kamath, Hugo E. Vargas, Liu Yang, Srinivasan Dasarathy, Nicole Welch, Annette Bellar, Amy Attaway, Jaividhya Dasarathy, Ashley Growley, David Streem, Laura E. Nagy, Mack C. Mitchell, H. Franklin Herlong, Thomas A. Kerr, Thomas G. Cotter, Arun J. Sanyal, Sara O'Connor, Velimir A. Luketic, Amon Asgharpour, Stephanie Taylor, Craig J. McClain, Vatsalya Vatsalya, Loretta Jophlin, Matt Cave, Suman Kumar Jha, Luis Marsano, Ashutosh Barve, Jane Frimodig, Ramón Bataller, Samhita Ravi, Jaideep Behari, Sharvari Shivanekar, Paula Cristina Steffen Novelli, Andrés Duarte‐Rojo, Naudia Jonassaint, Gyöngyi Szabó, Curry, Z. Gordon Jiang, Ushma Agarwal, M. Dockrell Hazel, Bernd Schnabl

2024Journal of Hepatology56 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePrednisoneRandomized controlled trialAnakinraInternal medicineGastroenterologyDiseaseAlcohol Consumption and Health EffectsDrug-Induced Hepatotoxicity and ProtectionLiver Disease Diagnosis and Treatment
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis | Litcius